FLNA

0.644015.00%
GT

George Thornton

Senior Vice President of Technology

Dr. George Thornton, also known as Ben, Ph.D. serves as Senior Vice President of Technology at Filana Therapeutics, Inc. (formerly known as Cassava Sciences, Inc.) (formerly known as Pain Therapeutics, Inc.) since 2005. Dr. Thornton served as Managing Director of Apovia, Inc. a subsidiary of Apovia AG. Dr. Thornton served as Executive Vice President of Research and Development of Apovia AG. Dr. Thornton is a Founder of Immune Complex Corporation and served as its President and Chief Executive Officer since 1996. He is recognized as an expert in pharmaceutical development and sits on the Board of Directors of the Infectious Disease Science Center of the Torrey Pines Institute for Molecular Studies (La Jolla). Dr. Thornton served as the Director of Research of the Pharmaceutical Research Institute (responsible for research centers in La Jolla, CA and Sydney, Australia). At Pain Therapeutics and formerly as Vice President of Research and Development at Apovia Pharmaceuticals, Dr. Thornton has been managing clinical trials worldwide for over 7 years. Prior to Immune, he served as Vice President of Preclinical Development and R&D for GeneMedicine, Inc., in Woodlands, Texas. Dr. Thornton served as Director of Pharmaceutical Research at RW Johnson (a Johnson & Johnson company) in San Diego and Australia for 15 years. He serves as Director of Zacharon Pharmaceuticals, Inc. He was a post-doctoral fellow at the Roche Institute of Molecular Biology. Dr. Thornton received his undergraduate degree from Abilene Christian University and his PhD from the University of Texas Graduate School of Biomedical Sciences (Houston).

Positions